Effects of systemic TNF inhibition on postprandial glucose-regulatory hormones in inflammatory arthritis
In patients initiating TNFi therapy, serum levels of GIP, amylin and PP increase regardless of systemic inflammation. This effect on postprandial glucose-regulating hormones may help explain the cardiovascular benefits of TNFi in rheumatic inflammatory diseases, at least in part.
Authors
- Mónica Renuncio‐García (ORCID: https://orcid.org/0000-0001-8991-3241)
- Iván Ferraz‐Amaro (ORCID: https://orcid.org/0000-0003-0197-5267)
- Ana Isabel Rodríguez Vargas
- Marta Hernández-Díaz (ORCID: https://orcid.org/0000-0002-0056-3132)
- Federico Díaz‐González (ORCID: https://orcid.org/0000-0002-4139-9295)
- Javier Gonzalo Ocejo-Vinyals (ORCID: https://orcid.org/0000-0003-2245-4639)
- Jorge García-Hernández (ORCID: https://orcid.org/0000-0003-3279-6210)
- Judith López‐Fernández
Institutions
- Universidad de La Laguna (ES)
- Hospital Universitario de Canarias (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Hospital Universitario de León (ES)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1093/rheumatology/keaf601
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00